dapirolizumab pegol: Clinical Trials

1 trial of dapirolizumab pegol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow dapirolizumab pegol: new trials by email Literature Review of dapirolizumab pegol trials Research Report on dapirolizumab pegol

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus
Placebo, Dapirolizumab pegol (DZP) - Systemic Lupus Erythematosus (SLE)
Phase 2CompletedUCB Biopharma S.P.R.L.1822016-06-022021-06-30

Conditions studied

Lupus Erythematosus, Systemic (1)

Sponsors

UCB Biopharma S.P.R.L. (1)

Countries

Bulgaria (1)  ·  Chile (1)  ·  Colombia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Peru (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Spain (1)  ·  Ukraine (1)  ·  United States (1)

Results publications

PMID 34897375, PMID 36453450

NIH funding

2015 (1)